Double Positive Anti‐ PR3 ANCA Vasculitis and Anti‐ GBM Vasculitis in a Pregnant Woman: Case Report
Nephrology · 2025
DOI: 10.1111/nep.70124 ↗Kurz gefasst
Fallbericht in der Zeitschrift Nephrology, 2025. Verfasst von Sumedh Jayanti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Renal Medicine, Westmead Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-Glomerular Basement Membrane Disease, Pregnancy Complications, Myeloblastin. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Pulmonary‐renal syndrome (PRS) caused by double‐positive ANCA‐associated vasculitis and anti‐GBM disease is rare, and management is primarily guided by case series evidence. We present an even rarer case of a 36‐year‐old female who developed PRS in early pregnancy due to double‐positive disease. She required intensive care admission for respiratory support and was treated with high‐dose steroids and two doses of rituximab (1 g), achieving a good pulmonary response. However, her renal function subsequently deteriorated. Given the high maternal and foetal risks associated with her condition, she chose to terminate her pregnancy at 8 weeks. A subsequent kidney biopsy revealed crescentic glomerulonephritis secondary to anti‐GBM disease. She was treated with plasma exchange and cyclophosphamide, leading to normalisation of her kidney function. She was weaned off prednisone and completed a course of intravenous pulsed cyclophosphamide (500 mg ×6 fortnightly). At 1 year post‐diagnosis, she remains in biochemical and clinical remission on maintenance rituximab every 6 months. This case highlights the complexity of managing double‐positive disease in pregnancy, where evidence is limited, and decisions require careful consideration of maternal and foetal risks. Furthermore, it underscores the importance of early anti‐GBM‐specific treatment—plasma exchange and cyclophosphamide—in achieving remission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Renal Medicine, Westmead Hospital, Sydney, New South Wales, Australia.
- Faculty of Health and Medicine, University of Sydney, Sydney, New South Wales, Australia.
- Centre for Transplant and Renal Research, Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
- Department of Anatomical Pathology, Westmead Hospital, Sydney, New South Wales, Australia.
- Department of Immunology, Westmead Hospital, Sydney, New South Wales, Australia.
- Department of Immunopathology, ICPMR, NSW Health Pathology, Sydney, New South Wales, Australia.
ORCID-Profile: Sumedh Jayanti
Zitieren
APA
Jayanti, S., Li, J., Renthawa, J., Lin, M. W., & Lee, V. (2025). Double Positive Anti‐ PR3 ANCA Vasculitis and Anti‐ GBM Vasculitis in a Pregnant Woman: Case Report. Nephrology. https://doi.org/10.1111/nep.70124
Vancouver
Jayanti S, Li J, Renthawa J, Lin MW, Lee V. Double Positive Anti‐ PR3 ANCA Vasculitis and Anti‐ GBM Vasculitis in a Pregnant Woman: Case Report. Nephrology. 2025. doi:10.1111/nep.70124
BibTeX
@article{Jayanti2025,
author = {Jayanti, Sumedh and Li, Jennifer and Renthawa, Jasveen and Lin, Ming-Wei and Lee, Vincent},
title = {Double Positive Anti‐ PR3 ANCA Vasculitis and Anti‐ GBM Vasculitis in a Pregnant Woman: Case Report},
journal = {Nephrology},
year = {2025},
doi = {10.1111/nep.70124}
}
EUVIMED